Advertisement

2 High-Risk, High-Reward Stocks for Contrarian Investors

2 High-Risk, High-Reward Stocks for Contrarian Investors

Uncovering gems in the stock market that most other investors are ignoring -- or actively avoiding -- can be highly profitable in the long term. Also, Bluebird has a couple of promising gene-editing therapies in the pipeline.